Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.963
-0.098 (-3.19%)
Jun 8, 2026, 2:17 PM EDT - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $535.08 million as of June 8, 2026. Its market cap has increased by 259.32% in one year.
Market Cap
535.08M
Enterprise Value
528.09M
1-Year Change
259.32%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $535.08M, a decrease of -67.12%. That is a compound annual growth rate of -26.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 552.69M | -10.03% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 579.21M |
| Gyre Therapeutics | 574.73M |
| MiMedx Group | 557.06M |
| Rigel Pharmaceuticals | 553.77M |
| Immix Biopharma | 553.44M |
| Tectonic Therapeutic | 547.21M |
| ProKidney | 543.71M |
| Ginkgo Bioworks Holdings | 536.97M |